Search Results - "Barter, Devra"

The hepatitis C cascade of care: identifying priorities to improve clinical outcomes by Linas, Benjamin P, Barter, Devra M, Leff, Jared A, Assoumou, Sabrina A, Salomon, Joshua A, Weinstein, Milton C, Kim, Arthur Y, Schackman, Bruce R

“…As highly effective hepatitis C virus (HCV) therapies emerge, data are needed to inform the development of interventions to improve HCV treatment rates. We…”
Get full text

Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study by Teillant, Aude, MS, Gandra, Sumanth, MD, Barter, Devra, MS, Morgan, Daniel J, MD, Laxminarayan, Ramanan, Prof

“…Summary Background The declining efficacy of existing antibiotics potentially jeopardises outcomes in patients undergoing medical procedures. We investigated…”
Get full text

The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic by Seagle, Emma E, Jackson, Brendan R, Lockhart, Shawn R, Georgacopoulos, Ourania, Nunnally, Natalie S, Roland, Jeremy, Barter, Devra M, Johnston, Helen L, Czaja, Christopher A, Kayalioglu, Hazal, Clogher, Paula, Revis, Andrew, Farley, Monica M, Harrison, Lee H, Davis, Sarah Shrum, Phipps, Erin C, Tesini, Brenda L, Schaffner, William, Markus, Tiffanie M, Lyman, Meghan M

“…Abstract Background The COVID-19 pandemic has resulted in unprecedented healthcare challenges, and COVID-19 has been linked to secondary infections…”
Get full text

Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review by Barter, Devra M, Agboola, Stephen O, Murray, Megan B, Bärnighausen, Till

“…Tuberculosis (TB) is known to disproportionately affect the most economically disadvantaged strata of society. Many studies have assessed the association…”
Get full text

Burden of Candidemia in the United States, 2017 by Tsay, Sharon V, Mu, Yi, Williams, Sabrina, Epson, Erin, Nadle, Joelle, Bamberg, Wendy M, Barter, Devra M, Johnston, Helen L, Farley, Monica M, Harb, Sasha, Thomas, Stepy, Bonner, Lindsay A, Harrison, Lee H, Hollick, Rosemary, Marceaux, Kaytlynn, Mody, Rajal K, Pattee, Brittany, Shrum Davis, Sarah, Phipps, Erin C, Tesini, Brenda L, Gellert, Anita B, Zhang, Alexia Y, Schaffner, William, Hillis, Sherry, Ndi, Danielle, Graber, Caroline R, Jackson, Brendan R, Chiller, Tom, Magill, Shelley, Vallabhaneni, Snigdha

“…Abstract Background Candidemia is a common healthcare-associated bloodstream infection with high morbidity and mortality. There are no current estimates of…”
Get full text

The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection by Linas, Benjamin P, Barter, Devra M, Morgan, Jake R, Pho, Mai T, Leff, Jared A, Schackman, Bruce R, Horsburgh, C Robert, Assoumou, Sabrina A, Salomon, Joshua A, Weinstein, Milton C, Freedberg, Kenneth A, Kim, Arthur Y

“…Chronic infection with hepatitis C virus (HCV) genotype 2 or 3 can be treated with sofosbuvir without interferon. Because sofosbuvir is costly, its benefits…”
Get full text

Hepatitis C Screening Trends in a Large Integrated Health System by Linas, Benjamin P., MD, MPH, Hu, Haihong, MS, MPH, Barter, Devra M., MS, Horberg, Michael, MD, MAS, FACP, FIDSA

“…Abstract Background As new hepatitis C virus (HCV) therapies emerge, only 1%-12% of individuals are screened in the US for HCV infection. Presently, HCV…”
Get full text

Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites—United States, 2017–2018 by Gold, Jeremy A W, Seagle, Emma E, Nadle, Joelle, Barter, Devra M, Czaja, Christopher A, Johnston, Helen, Farley, Monica M, Thomas, Stepy, Harrison, Lee H, Fischer, Jill, Pattee, Brittany, Mody, Rajal K, Phipps, Erin C, Davis, Sarah Shrum, Tesini, Brenda L, Zhang, Alexia Y, Markus, Tiffanie M, Schaffner, William, Lockhart, Shawn R, Vallabhaneni, Snigdha, Jackson, Brendan R, Lyman, Meghan

“…Abstract Background Candidemia is a common opportunistic infection causing substantial morbidity and mortality. Because of an increasing proportion of…”
Get full text

Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs by Schackman, Bruce R., Leff, Jared A., Barter, Devra M., DiLorenzo, Madeline A., Feaster, Daniel J., Metsch, Lisa R., Freedberg, Kenneth A., Linas, Benjamin P.

“…Aims To evaluate the cost‐effectiveness of rapid hepatitis C virus (HCV) and simultaneous HCV/HIV antibody testing in substance abuse treatment programs…”
Get full text

The Estimated Health and Economic Benefits of Three Decades of Polio Elimination Efforts in India by Nandi, Arindam, Barter, Devra M, Prinja, Shankar, John, T Jacob

“…In March 2014, India, the country with historically the highest burden of polio, was declared polio free, with no reported cases since January 2011. We…”
Get full text

Epidemiology of Extrapulmonary Nontuberculous Mycobacterial Disease – 4 Emerging Infection Program Sites, 2021 by Byram, Rebecca, Jackson, Kelly, Czaja, Christopher, Johnston, Helen, Barter, Devra, Lynfield, Ruth, Centurion, Nathan, Tourdot, Laura, Dumyati, Ghinwa, Myers, Christopher, Pierce, Rebecca, Charles Toney, Nadege, Mansour, Adel, Magill, Shelley, See, Isaac

“…Background: Extrapulmonary nontuberculous mycobacteria (ENTM) infections are difficult to treat and often require prolonged therapy or surgery. Few…”
Get full text

The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients by LINAS, Benjamin P, BARTER, Devra M, FREEDBERG, Kenneth A, LEFF, Jared A, DILORENZO, Madeline, SCHACKMAN, Bruce R, HORSBURGH, Charles R, ASSOUMOU, Sabrina A, SALOMON, Joshua A, WEINSTEIN, Milton C, KIME, Arthur Y

“…To evaluate the effectiveness and cost-effectiveness of strategies to treat hepatitis C virus (HCV) in HIV/HCV coinfected patients in the United States…”
Get full text

Candida Bloodstream Infections Among Persons Who Inject Drugs — Denver Metropolitan Area, Colorado, 2017–2018 by Barter, Devra M., Johnston, Helen L., Williams, Sabrina R., Tsay, Sharon V., Vallabhaneni, Snigdha, Bamberg, Wendy M.

“…Candidemia, a bloodstream infection caused by Candida species, is typically considered a health care-associated infection, with known risk factors including…”
Get full text

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel by Pilishvili, Tamara, Gierke, Ryan, Fleming-Dutra, Katherine E, Farrar, Jennifer L, Mohr, Nicholas M, Talan, David A, Krishnadasan, Anusha, Harland, Karisa K, Smithline, Howard A, Hou, Peter C, Lee, Lilly C, Lim, Stephen C, Moran, Gregory J, Krebs, Elizabeth, Steele, Mark T, Beiser, David G, Faine, Brett, Haran, John P, Nandi, Utsav, Schrading, Walter A, Chinnock, Brian, Henning, Daniel J, Lovecchio, Frank, Lee, Jane, Barter, Devra, Brackney, Monica, Fridkin, Scott K, Marceaux-Galli, Kaytlynn, Lim, Sarah, Phipps, Erin C, Dumyati, Ghinwa, Pierce, Rebecca, Markus, Tiffanie M, Anderson, Deverick J, Debes, Amanda K, Lin, Michael Y, Mayer, Jeanmarie, Kwon, Jennie H, Safdar, Nasia, Fischer, Marc, Singleton, Rosalyn, Chea, Nora, Magill, Shelley S, Verani, Jennifer R, Schrag, Stephanie J

“…In a test-negative case–control study involving 1482 vaccinated health care workers and 3449 controls, the BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines were…”
Get full text

Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot by Grigg, Cheri, Jackson, Kelly A, Barter, Devra, Czaja, Christopher A, Johnston, Helen, Lynfield, Ruth, Vagnone, Paula Snippes, Tourdot, Laura, Spina, Nancy, Dumyati, Ghinwa, Cassidy, P Maureen, Pierce, Rebecca, Henkle, Emily, Prevots, D Rebecca, Salfinger, Max, Winthrop, Kevin L, Toney, Nadege Charles, Magill, Shelley S

“…Abstract Background Nontuberculous mycobacteria (NTM) cause pulmonary (PNTM) and extrapulmonary (ENTM) disease. Infections are difficult to diagnose and treat,…”
Get full text

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017 by Zhang, Alexia Y, Shrum, Sarah, Williams, Sabrina, Petnic, Sarah, Nadle, Joelle, Johnston, Helen, Barter, Devra, Vonbank, Brittany, Bonner, Lindsay, Hollick, Rosemary, Marceaux, Kaytlynn, Harrison, Lee, Schaffner, William, Tesini, Brenda L, Farley, Monica M, Pierce, Rebecca A, Phipps, Erin, Mody, Rajal K, Chiller, Tom M, Jackson, Brendan R, Vallabhaneni, Snigdha

“…Abstract Background Injection drug use (IDU) is a known, but infrequent risk factor on candidemia; however, the opioid epidemic and increases in IDU may be…”
Get full text

Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites - United States, 2019-2020 by Masters, Thao L, Toney, Nadege Charles, Ewing, Thomas O, McAllister, Gillian, Mathis, Marsenia H, Grigg, Cheri, Magill, Shelley S, Jackson, Kelly A, Byram, Rebecca, See, Isaac, Salfinger, Max, Barter, Devra, Johnston, Helen, Lynfield, Ruth, Vagnone, Paula Snippes, Tourdot, Laura, Anderson, Bridget J, Dumyati, Ghinwa, Pierce, Rebecca, Lutgring, Joseph D, Gargis, Amy, McKay, Susannah

“…Nontuberculous mycobacteria (NTM) cause pulmonary and extrapulmonary infections. Although isolation of NTM from clinical specimens has increased nationally,…”
Get full text

Antimicrobial Use in a Cohort of US Nursing Homes, 2017 by Thompson, Nicola D, Stone, Nimalie D, Brown, Cedric J, Penna, Austin R, Eure, Taniece R, Bamberg, Wendy M, Barney, Grant R, Barter, Devra, Clogher, Paula, DeSilva, Malini B, Dumyati, Ghinwa, Frank, Linda, Felsen, Christina B, Godine, Deborah, Irizarry, Lourdes, Kainer, Marion A, Li, Linda, Lynfield, Ruth, Mahoehney, J. P, Maloney, Meghan, Nadle, Joelle, Ocampo, Valerie L. S, Pierce, Rebecca, Ray, Susan M, Davis, Sarah Shrum, Sievers, Marla, Srinivasan, Krithika, Wilson, Lucy E, Zhang, Alexia Y, Magill, Shelley S

“…IMPORTANCE: Controlling antimicrobial resistance in health care is a public health priority, although data describing antimicrobial use in US nursing homes are…”
Get full text

Residential social vulnerability among healthcare personnel with and without severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in Five US states, May–December 2020 by Zlotorzynska, Maria, Chea, Nora, Eure, Taniece, Alkis Ramirez, Rebecca, Blazek, Gregory T., Czaja, Christopher A., Johnston, Helen, Barter, Devra, Kellogg, Melissa, Emanuel, Catherine, Lynfield, Ruth, Fell, Ashley, Lim, Sarah, Lovett, Sara, Phipps, Erin C., Shrum Davis, Sarah, Sievers, Marla, Dumyati, Ghinwa, Concannon, Cathleen, Myers, Christopher, McCullough, Kathryn, Woods, Amy, Hurley, Christine, Licherdell, Erin, Pierce, Rebecca, Ocampo, Valerie L.S., Hall, Eric, Magill, Shelley S., Grigg, Cheri T.

“…To characterize residential social vulnerability among healthcare personnel (HCP) and evaluate its association with severe acute respiratory coronavirus virus…”
Get full text

Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020–December 2021 by Chea, Nora, Eure, Taniece, Alkis Ramirez, Rebecca, Zlotorzynska, Maria, Blazek, Gregory T., Nadle, Joelle, Lee, Jane, Czaja, Christopher A., Johnston, Helen, Barter, Devra, Kellogg, Melissa, Emanuel, Catherine, Meek, James, Brackney, Monica, Carswell, Stacy, Thomas, Stepy, Fridkin, Scott K., Wilson, Lucy E., Perlmutter, Rebecca, Marceaux-Galli, Kaytlynn, Fell, Ashley, Lovett, Sara, Lim, Sarah, Lynfield, Ruth, Shrum Davis, Sarah, Phipps, Erin C., Sievers, Marla, Dumyati, Ghinwa, Myers, Christopher, Hurley, Christine, Licherdell, Erin, Pierce, Rebecca, Ocampo, Valerie L. S., Hall, Eric W., Wilson, Christopher, Adre, Cullen, Kirtz, Erika, Markus, Tiffanie M., Billings, Kathryn, Plumb, Ian D, Abedi, Glen R., James-Gist, Jade, Magill, Shelley S., Grigg, Cheri T.

“…Understanding characteristics of healthcare personnel (HCP) with SARS-CoV-2 infection supports the development and prioritization of interventions to protect…”
Get full text